Stamford, CT -- (SBWIRE) -- 01/15/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Lantronix Inc (NASDAQ:LTRX), China Pharma Holdings, Inc. (NYSEMKT:CPHI), Hemispherx BioPharma, Inc (NYSEMKT:HEB), DARA Biosciences Inc (NASDAQ:DARA)
Lantronix Inc (NASDAQ:LTRX) opened the session at $1.76, trading in a range of $1.76 - $2.50. The stock showed a positive performance of +29.21% in the last trading session from its previous close of $1.78 and closed at $2.30. The stock traded on a volume of 1.44 million shares and the average volume of the stock remained 33,713 shares. Lantronix, Inc. designs, develops, markets and sells products that make it possible to access, manage, control and configure electronic products over the Internet or other networks. Its device management solutions address applications that manage equipment at data centers and remote branch offices to provide management for information technology (IT) systems.
For How Long LTRX will Fight for Profitability? Read This Trend Analysis report
China Pharma Holdings, Inc. (NYSEMKT:CPHI) traded 4.44 million shares in the last business day while the average volume of the stock remained 84,887 shares. The stock showed a positive movement of +28.52% to end at $0.540. The 52 week range of the stock remained $0.19 - $0.80. China Pharma Holdings, Inc. is engaged in the development, manufacture and marketing of pharmaceutical products for human uses in connection with a range of high-incidence and high-mortality diseases and medical conditions in the People's Republic of China (the PRC). All of the Company's operations are conducted in the PRC, where its manufacturing facilities are located.
For How Long CPHI’s Gloss will Attract Investors? Find out via this report
Hemispherx BioPharma, Inc (NYSEMKT:HEB) reported 417.21 million shares were exchanged during the last trade, while the average volume is about 2.41 million shares. The stock escalated +23.74% and finished the day at $0.430. The beta of the stock is recorded at 1.77. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection
For How Long HEB’s Gloss will Attract Investors? Find out via this report
DARA Biosciences Inc (NASDAQ:DARA) shares rose, +19.53 percent from its previous close of $0.64 to close at $0.765. Traded with volume of 8.53 million shares in the prior session and the average volume of the stock remained 1.23 million shares. DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. The Company has the exclusive United States marketing rights to its Soltamox (oral liquid tamoxifen).
Why Should Investors Buy DARA After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)